Reglan is a drug that’s used primarily to help people deal with gastrointestinal problems, and it’s manufactured by Baxter Pharmaceuticals. Reglan is only available via prescription, and the drug has been under scrutiny lately from such entities as the US Food and Drug Administration (FDA), and it’s currently under review in terms of whether or not its benefits outweigh its risks when deciding whether or not it will remain on the market in the United States.
Reglan is used primarily to treat and help with two common gastrointestinal problems:
Reglan works by speeding up the rate at which the muscles in the upper digestive tract contract, thereby creating a process where its contents move into the intestinal tract at a faster rate.
^ Back To TopThe FDA approval process for Reglan can actually be traced back to 1985, when metoclopramide, the main active ingredient in Reglan, was approved by the FDA for medications as an active substance. Reglan was individually approved by the FDA for sale in the United States in 1999, and as is the case with any drug’s approval, it was obtained based on the results of studies performed in controlled environments.
^ Back To TopThe side effects that have been linked to Reglan are the reason that the drug and Baxter Pharmaceuticals are in their current position, as there were reports generated that prompted the FDA to take immediate action. However, there were some side effects associated with Reglan in the past that were not seen as common enough to warrant governmental involvement, and they included:
The side effect that reached a level of prevalence that prompted the government to act was a rare condition known as Tardive Dyskinesia (TD). TD is a condition that is largely unknown at this point. Specifically, this means that scientists are still debating theories as to how it originally forms in the body and advances, and at this time there is no cure available for TD.
Symptoms of TD include a series of rapid, sometimes continuous movements of the following areas of the body:
These movements can become so severe and rapid in nature that basic daily functions of life become difficult if not impossible. For instance, if the legs are affected by TD to a severe enough degree, patients can lose the ability to walk on a regular basis. There are medications available that will mitigate the symptoms, but anyone who contracts TD faces a lifetime of stress, struggle and extreme difficulties.
Of the limited discoveries made in relation to Reglan, one that stands out is that those who take these medications for any period of time longer than a few weeks tend to greatly increase the risks involved with the side effects associated with Reglan.
While there was no definitive action by the FDA in relation to Reglan until recently, there were reports of some side effects with the drug. However, this is common among a majority of medications that hit the market. These side effects included:
While some of these side effects were dangerous, they were not prevalent enough to warrant official action.
^ Back To TopReglan is a specialized drug, which means that there have been instances of contraindications in the past. Some of these types of medications include:
What prompted action by the FDA against Reglan?
The FDA acts on a reactionary basis after a drug is approved. This means that if enough reports are generated that detail a link between a medication and serious side effects, the FDA will study the issue and act accordingly.
Why did the FDA require a ‘REMS’ study?
A REMS study is a study that is meant to define if a medication’s risks are worth keeping it on the market based on the benefits it provides. A REMS can lead ultimately to a recall, but that is not always the case.
What should I do if I’ve taken Reglan and developed side effects?
If you’ve used Reglan and been injured, you need to take action. Contact the attorneys available for free initial consultations at http://www.resource4defectivedrugs.com today.
^ Back To Top
Begin your case review by filling out the form below or call us 24 hours a day/ 7 days a week at 1-800-819-1000